Blau Farmacêutica S.A. (BVMF:BLAU3)

Market Cap	2.30B
Revenue (ttm)	1.77B
Net Income (ttm)	268.05M
Shares Out	177.68M
EPS (ttm)	1.50
PE Ratio	8.61
Forward PE	7.42
Dividend	0.36 (2.79%)
Ex-Dividend Date	Mar 24, 2025

Volume	149,100
Average Volume	416,245
Open	13.26
Previous Close	12.92
Day's Range	12.81 - 13.48
52-Week Range	9.20 - 17.61
Beta	0.36
RSI	55.22
Earnings Date	May 7, 2025

About Blau Farmacêutica

Blau Farmacêutica S.A., a pharmaceutical company provides high-complpexity drugs in Brazil, Argentina, Chile, Colombia, Uruguay, Ecuador, Peru, and the United States. Its medications cover various segments, such as immunology, hematology, oncology, nephrology, infectious diseases, anesthesiology, and others. The company provides uterine stimulator; anesthetics; feminine health care; oncological products; antivirals and antiretrovirals; acid pump inhibitor; antithrombotic; antirheumatic; antibiotics; biopharmaceuticals; essential hospital produc...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1987
• Employees: 1,900
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: BLAU3

Financial Performance

In 2024, Blau Farmacêutica's revenue was 1.75 billion, an increase of 27.81% compared to the previous year's 1.37 billion. Earnings were 217.21 million, a decrease of -13.05%.